GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Antibody
Comment: Zadoprubart is the INN for an anti-B and T lymphocyte attenuator (BTLA) monoclonal antibody. IMGT associate the INN with AnaptysBio clinical research code ANB032.
|
| Immunopharmacology Comments |
| Zadoprubart targets B and T lymphocyte attenuator (BTLA) and was developed for potential immune checkpoint inhibitory, immunomodulating and antineoplastic activities. |